EPR investigation of the active site of recombinant human 5-lipoxygenase:: Inhibition by selenide

被引:27
|
作者
Hammarberg, T [1 ]
Kuprin, S [1 ]
Rådmark, O [1 ]
Holmgren, A [1 ]
机构
[1] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden
关键词
D O I
10.1021/bi001595d
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Lipoxygenases are a group of non-heme iron dioxygenases which catalyze the formation of lipid hydroperoxides from unsaturated fatty acids. 5-Lipoxygenase (5LO) is of particular interest for formation of leukotrienes and lipoxins, implicated in inflammatory processes. In this study, electron paramagnetic resonance (EPR) spectroscopy was used to investigate the active site iron of purified recombinant human 5-lipoxygenase (5LO), and to explore the action of selenide on 5LO. After oxidation by lipid hydroperoxides, 5LO exhibited axial EPR spectra typified by a signal at g = 6.2. However, removal of the lipid hydroperoxides, their metabolites, and the solvent ethanol from the samples resulted in a shift to more rhombic EPR spectra (g = 5.17 and g = 9.0). Thus, many features of 5LO and soybean lipoxygenase-l EPR spectra were similar, indicating similar flexible iron ligand arrangements in these lipoxygenases. Selenide (1.5 muM) showed a strong inhibitory effect on the enzyme activity of 5LO. In EPR, selenide abolished the signal at g = 6.2, typical for enzymatically active 5LO. Lipid hydroperoxide added to selenide-treated 5LO could not reinstate the signal at g = 6.2, indicating an irreversible change of the coordination of the active site iron.
引用
收藏
页码:6371 / 6378
页数:8
相关论文
共 50 条
  • [1] The mode of substrate entry into the 5-lipoxygenase active site
    Mitra, Sunayana
    Newcomer, Marcia
    FASEB JOURNAL, 2014, 28 (01):
  • [2] INHIBITION OF HUMAN NEUTROPHIL 5-LIPOXYGENASE BY GALLATES
    WOZEL, G
    SCHRODER, JM
    CHRISTOPHERS, E
    BARTH, J
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1988, 91 (04) : 400 - 400
  • [3] Flavonoids of cocoa inhibit recombinant human 5-lipoxygenase
    Schewe, T
    Kühn, H
    Sies, H
    JOURNAL OF NUTRITION, 2002, 132 (07): : 1825 - 1829
  • [4] Elucidating the Open and Active Conformation of Human 5-Lipoxygenase
    Gallegos, Eden
    Gilbert, Nathaniel
    Newcomer, Marcia
    FASEB JOURNAL, 2020, 34
  • [5] Kinetic investigation of human 5-lipoxygenase with arachidonic acid
    Mittal, Monica
    Kumar, Ramakrishnan B.
    Balagunaseelan, Navisraj
    Hamberg, Mats
    Jegerschold, Caroline
    Radmark, Olof
    Haeggstrom, Jesper Z.
    Rinaldo-Matthis, Agnes
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (15) : 3547 - 3551
  • [6] Calcium binding site of 5-lipoxygenase
    Hammarberg, T
    Provost, P
    Reddy, KV
    Persson, B
    Rådmark, O
    ADVANCES IN PROSTAGLANDIN AND LEUKOTRIENE RESEARCH: BASIC SCIENCE AND NEW CLINICAL APPLICATIONS, 2001, 16 : 17 - 20
  • [7] 5-lipoxygenase inhibition in the treatment of asthma
    Drazen, JM
    FROM GENETICS TO QUALITY OF LIFE: THE OPTIMAL TREATMENT AND MANAGEMENT OF ASTHMA, 1996, : 161 - 165
  • [8] Inhibition of 5-lipoxygenase by pyridinone derivatives
    Xie, WL
    Ma, L
    Guo, GJ
    Duan, ZF
    Zou, L
    Gu, LQ
    Wang, J
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2002, 29 (04) : 588 - 591
  • [9] KINETIC MECHANISMS OF INHIBITION OF 5-LIPOXYGENASE
    AHARONY, D
    STEIN, RL
    FEDERATION PROCEEDINGS, 1987, 46 (06) : 1971 - 1971
  • [10] Pharmacological aspects of 5-lipoxygenase inhibition
    Müller-Peddinghaus, R
    LIPOXYGENASES AND THEIR METABOLITES: BIOLOGICAL FUNCTIONS, 1999, 447 : 117 - 121